ReviewCureus2025

Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review.

Ricardo Flaminio Rojas Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.